Hunt BioVentures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 17

  • Portfolio
  • 1

  • Exits
  • 14


Hunt BioVentures General Information


Hunt BioVentures was a venture capital firm that used to makes investments in young private and public firms with a focus on pharmaceuticals, medical devices and agricultural biotech opportunities. It was founded in 2001 and was based in Dallas, Texas.

Contact Information

Year Founded
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • 1900 North Akard Street
  • Dallas, TX 75201
  • United States

Hunt BioVentures Investments (17)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Raven 02-May-2018 Later Stage VC 00.00 Media and Information Services (B2B) Generating Revenue
Revance Therapeutics 16-Jan-2014 00000 00000 000.00 Drug Delivery Generating Revenue/Not Profitable
OvaScience 04-Apr-2012 00000 00000 000.00 Biotechnology Generating Revenue
Synageva BioPharma 22-Oct-2009 00000 00000 0000 Biotechnology Generating Revenue
Cempra Pharmaceuticals 14-May-2009 00000 00000 0000 Pharmaceuticals Profitable
InteKrin 19-Mar-2008 00000 00000 000.00 Pharmaceuticals Clinical Trials - General
IntelliDx 19-Mar-2008 00000 00000 000.00 Monitoring Equipment Out of Business
Peptimmune 17-Jan-2008 00000 00000 000.00 Pharmaceuticals Bankruptcy: Liquidation
Sirtris Pharmaceuticals 06-Feb-2007 Later Stage VC 0000 Pharmaceuticals Generating Revenue
Morphotek 13-Oct-2006 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 17 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hunt BioVentures Exits (14)

Company Name Exit Date Exit Type Exit Size
InteKrin 12-Feb-2014 Merger/Acquisition 000
Revance Therapeutics 06-Feb-2014 000 0000
MacroGenics 10-Oct-2013 000 000.00
OvaScience 12-Nov-2012 000 000.00
Cempra Pharmaceuticals 03-Feb-2012 000 000.00
Synageva BioPharma 03-Nov-2011 0000000 000000 00000
Peptimmune 23-Mar-2011 0000000000: 000000
Athenix 02-Nov-2009 000000000000000000 00000
IntelliDx 01-Jan-2009 Bankruptcy: Liquidation
Sirtris Pharmaceuticals 05-Jun-2008 Merger/Acquisition 00000
You’re viewing 10 of 14 exits. Get the full list »

Hunt BioVentures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial